Kristen Marie Williams is Chief Administrative Officer of Pacira BioSciences, Inc.. Currently has a direct ownership of 102,912 shares of PCRX, which is worth approximately $1.81 Million. The most recent transaction as insider was on Jun 13, 2024, when has been sold 7,452 shares (Common Stock) at a price of $28.38 per share, resulting in proceeds of $211,487. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 103K
0% 3M change
305.56% 12M change
Total Value Held $1.81 Million

Kristen Marie Williams Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2024
SELL
Open market or private sale
$211,487 $28.38 p/Share
7,452 Reduced 6.75%
102,912 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
54,300 Added 32.98%
110,364 Common Stock
Jun 03 2024
SELL
Payment of exercise price or tax liability
$93,009 $30.89 p/Share
3,011 Reduced 5.1%
56,064 Common Stock
Feb 05 2024
BUY
Grant, award, or other acquisition
-
33,700 Added 36.32%
59,075 Common Stock
Jun 14 2023
SELL
Open market or private sale
$239,473 $37.03 p/Share
6,467 Reduced 20.31%
25,375 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
10,950 Added 25.59%
31,842 Common Stock
Jun 07 2023
SELL
Open market or private sale
$51,389 $37.87 p/Share
1,357 Reduced 6.1%
20,892 Common Stock
Jun 06 2023
SELL
Open market or private sale
$50,725 $38.99 p/Share
1,301 Reduced 5.52%
22,249 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
9,900 Added 29.6%
23,550 Common Stock
Jun 07 2022
SELL
Open market or private sale
$276,662 $59.51 p/Share
4,649 Reduced 25.41%
13,650 Common Stock
Jun 06 2022
SELL
Open market or private sale
$243,578 $61.37 p/Share
3,969 Reduced 17.82%
18,299 Common Stock
Mar 21 2022
SELL
Open market or private sale
$527,075 $72.67 p/Share
7,253 Reduced 24.57%
22,268 Common Stock
Mar 21 2022
BUY
Exercise of conversion of derivative security
$313,185 $43.18 p/Share
7,253 Added 19.72%
29,521 Common Stock
Feb 25 2022
SELL
Open market or private sale
$135,382 $66.04 p/Share
2,050 Reduced 8.43%
22,268 Common Stock
Feb 25 2022
BUY
Exercise of conversion of derivative security
$78,617 $38.35 p/Share
2,050 Added 7.77%
24,318 Common Stock
Feb 16 2022
SELL
Open market or private sale
$650 $65.0 p/Share
10 Reduced 0.04%
22,268 Common Stock
Feb 16 2022
BUY
Exercise of conversion of derivative security
$383 $38.35 p/Share
10 Added 0.04%
22,278 Common Stock
Feb 10 2022
SELL
Open market or private sale
$52,144 $65.18 p/Share
800 Reduced 3.47%
22,268 Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
$30,680 $38.35 p/Share
800 Added 3.35%
23,068 Common Stock
Feb 04 2022
SELL
Open market or private sale
$65,180 $65.18 p/Share
1,000 Reduced 4.3%
22,268 Common Stock
Feb 04 2022
BUY
Exercise of conversion of derivative security
$38,350 $38.35 p/Share
1,000 Added 4.12%
23,268 Common Stock
Jan 21 2022
SELL
Open market or private sale
$13,082 $65.41 p/Share
200 Reduced 0.89%
22,268 Common Stock
Jan 21 2022
BUY
Exercise of conversion of derivative security
$7,670 $38.35 p/Share
200 Added 0.88%
22,468 Common Stock
Jan 19 2022
SELL
Open market or private sale
$144,056 $65.51 p/Share
2,199 Reduced 8.99%
22,268 Common Stock
Jan 19 2022
BUY
Exercise of conversion of derivative security
$84,332 $38.35 p/Share
2,199 Added 8.25%
24,467 Common Stock
KMW

Kristen Marie Williams

Chief Administrative Officer
Tampa, FL

Track Institutional and Insider Activities on PCRX

Follow Pacira BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

News

Receive news related to Pacira BioSciences, Inc.

Track Activities on PCRX